Weight-loss medications may increase the risk of hair loss by up to 68 percent

Date:

Share this article:

Del denne artikel:

A new study suggests that people using popular weight-loss medications may face a higher risk of hair loss.

Wegovy and Mounjaro are used by millions of people for weight loss.

The best-known side effects include nausea, fatigue, and constipation, but researchers are now also investigating a possible link to hair loss, according to the Sun.

According to researchers at the University of Pennsylvania, rapid weight loss can lead to deficiencies in nutrients such as zinc and iron.

This may affect the hair's normal growth cycle, according to a study published in the British Medical Journal.

Also read: From teachers to drivers: The jobs linked to hidden health problems

More people have reported hair loss

UK health authorities consider hair loss to be a common or very common side effect of the treatment.

At the same time, the Medicines and Healthcare products Regulatory Agency in the UK has received 1,252 reports of hair loss from people who have used semaglutide or tirzepatide.

However, the researchers emphasize that rapid weight loss itself can also cause hair loss, even if it is not related to the medication. The condition is often temporary, and hair may grow back over time.

Study found a difference

The researchers compared around 24,000 people with type 2 diabetes who received either GLP-1 medication or alternative treatment.

Also read: Popular weight-loss drugs face new hair loss questions

The results showed that users of the weight-loss injections had up to a 68 percent higher risk of alopecia than those in the other group. The risk was highest among women.

According to the British Medical Journal, the study identified an association but does not prove that the medications are the direct cause of the hair loss.

Also read: New study finds drug reversed autism-like brain changes within hours

This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.

Other articles

How you think about getting older could decide whether your body and mind actually improve

A Yale study of more than 11,000 older adults found nearly half actually improved over 12 years.

On Jardiance or Farxiga? Three factors may sharply raise your risk of a serious complication

A large Scandinavian study pinpoints who is most vulnerable to a hard-to-spot side effect.

One urine sample caught 92% of bladder cancers, sparing patients the scope

An at-home urine test picked up more than nine in ten bladder cancers in a UK hospital trial.

A new calculator may help more heart failure patients finally get the treatment they need

A tool unveiled at ESC Congress 2026 puts personalized side-effect estimates in front of doctors.

How you think about getting older could decide whether your body and mind actually improve

A Yale study of more than 11,000 older adults found nearly half actually improved over 12 years.

On Jardiance or Farxiga? Three factors may sharply raise your risk of a serious complication

A large Scandinavian study pinpoints who is most vulnerable to a hard-to-spot side effect.

One urine sample caught 92% of bladder cancers, sparing patients the scope

An at-home urine test picked up more than nine in ten bladder cancers in a UK hospital trial.